Insider · CIK 0001682735

Peterson Amy C.

Reports to the SEC for 3 companies · ALAMEDA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001682735

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-16	EXELEXELIXIS, INC.M Exercise/Conversion	EVP Prod Dev & Med Aff & CMO	MExercise/Conversion	+40K sh	$21.75	+$870K	538,169
2025-05-16	EXELEXELIXIS, INC.S Sale	EVP Prod Dev & Med Aff & CMO	SSale	−72.8K sh	$45.47	−$3.31M	465,393
2025-05-16	EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion	EVP Prod Dev & Med Aff & CMO	MExercise/Conversion	−40K sh	—	—	120,000
2025-05-15	EXELEXELIXIS, INC.F Tax Payment	EVP Prod Dev & Med Aff & CMO	FTax Payment	−8,303 sh	$44.65	−$371K	498,169
2025-03-31	EXELEXELIXIS, INC.A Award	EVP Prod Dev & Med Aff & CMO	AAward	+159K sh	—	—	506,472
2025-02-26	EXELEXELIXIS, INC.A Award	EVP Prod Dev & Med Aff & CMO	AAward	+52.2K sh	—	—	347,089
2024-11-15	EXELEXELIXIS, INC.F Tax Payment	EVP Prod Dev & Med Aff & CMO	FTax Payment	−27.2K sh	$35.05	−$954K	294,897
2024-02-23	EXELEXELIXIS, INC.A Award	EVP Prod Dev & Med Aff & CMO	AAward	+82.1K sh	—	—	322,121
2023-08-24	EXELEXELIXIS, INC.A Award	EVP Prod Dev & Med Aff & CMO	AAward	+240K sh	—	—	240,000
2023-08-24	EXELEXELIXIS, INC. · Option (right to buy)A Award	EVP Prod Dev & Med Aff & CMO	AAward	+160K sh	—	—	160,000
2023-03-16	CTMXCytomX Therapeutics, Inc.S Sale	EVP, Chief Development Officer	SSale	−4,257 sh	$1.98	−$8,424.603	58,433
2022-07-20	CTMXCytomX Therapeutics, Inc.S Sale	EVP, Chief Development Officer	SSale	−7,463 sh	$1.42	−$10.6K	62,690
2022-07-19	CTMXCytomX Therapeutics, Inc.A Award	EVP, Chief Development Officer	AAward	+20K sh	—	—	70,153
2022-02-02	CTMXCytomX Therapeutics, Inc.A Award	EVP, Chief Development Officer	AAward	+40K sh	—	—	46,421
2022-02-02	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	EVP, Chief Development Officer	AAward	+200K sh	—	—	200,000
2021-10-24	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	EVP, Chief Development Officer	AAward	+50K sh	—	—	50,000
2021-10-24	CTMXCytomX Therapeutics, Inc. · Performance Stock Units (PSUs)A Award	EVP, Chief Development Officer	AAward	+40K sh	—	—	40,000
2021-05-31	CTMXCytomX Therapeutics, Inc.A Award	EVP, Chief Development Officer	AAward	+3,320 sh	$6.09	+$20.2K	6,421
2021-02-26	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, Chief Development Officer	AAward	+250K sh	—	—	250,000
2020-11-30	CTMXCytomX Therapeutics, Inc.A Award	EVP, Chief Development Officer	AAward	+3,101 sh	$6.39	+$19.8K	3,101
2020-02-14	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, Chief Development Officer	AAward	+25K sh	—	—	25,000
2019-10-15	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	EVP, Chief Development Officer	AAward	+400K sh	—	—	400,000
2018-12-18	ONCBeOne Medicines Ltd.M Exercise/Conversion	CMO, Immuno-oncology	MExercise/Conversion	+10.1K sh	$29.10	+$295K	10,141
2018-12-18	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−1,631 sh	$131.74	−$215K	8,510
2018-12-18	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−1,897 sh	$132.70	−$252K	6,613
2018-12-18	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−2,402 sh	$133.88	−$322K	4,211
2018-12-18	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−3,600 sh	$134.81	−$485K	611
2018-12-18	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−611 sh	$135.54	−$82.8K	0
2018-12-18	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	CMO, Immuno-oncology	MExercise/Conversion	−132K sh	—	—	820,000
2018-12-17	ONCBeOne Medicines Ltd.M Exercise/Conversion	CMO, Immuno-oncology	MExercise/Conversion	+9,859 sh	$29.10	+$287K	9,859
2018-12-17	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−900 sh	$130.37	−$117K	8,959
2018-12-17	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−2,700 sh	$131.80	−$356K	6,259
2018-12-17	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−1,700 sh	$132.91	−$226K	4,559
2018-12-17	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−1,005 sh	$133.81	−$134K	3,554
2018-12-17	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−778 sh	$135.04	−$105K	2,776
2018-12-17	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−2,296 sh	$136.24	−$313K	480
2018-12-17	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−480 sh	$136.93	−$65.7K	0
2018-12-17	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	CMO, Immuno-oncology	MExercise/Conversion	−128K sh	—	—	951,833
2018-11-12	ONCBeOne Medicines Ltd.M Exercise/Conversion	CMO, Immuno-oncology	MExercise/Conversion	+12.1K sh	$29.10	+$351K	12,067
2018-11-12	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−2,958 sh	$111.10	−$329K	9,109
2018-11-12	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−4,000 sh	$112.18	−$449K	5,109
2018-11-12	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−2,527 sh	$113.03	−$286K	2,582
2018-11-12	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−1,173 sh	$113.92	−$134K	1,409
2018-11-12	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−700 sh	$114.96	−$80.5K	709
2018-11-12	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−500 sh	$116.56	−$58.3K	209
2018-11-12	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−109 sh	$117.61	−$12.8K	100
2018-11-12	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−100 sh	$121.56	−$12.2K	0
2018-11-12	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	CMO, Immuno-oncology	MExercise/Conversion	−157K sh	—	—	1,080,000
2018-11-09	ONCBeOne Medicines Ltd.M Exercise/Conversion	CMO, Immuno-oncology	MExercise/Conversion	+13.2K sh	$29.10	+$385K	13,222
2018-11-09	ONCBeOne Medicines Ltd.S Sale	CMO, Immuno-oncology	SSale	−4,031 sh	$118.64	−$478K	9,191

Recent filings

Accepted (ET)
May 164
Peterson Amy C.0000939767-25-000076
SEC(opens sec.gov)
Mar 314
Peterson Amy C.0000939767-25-000055
SEC(opens sec.gov)
Feb 284
Peterson Amy C.0000939767-25-000040
SEC(opens sec.gov)
Nov 194
Peterson Amy C.0000939767-24-000158
SEC(opens sec.gov)
Feb 274
Peterson Amy C.0000939767-24-000035
SEC(opens sec.gov)
Aug 254
Peterson Amy C.0000939767-23-000098
SEC(opens sec.gov)
Mar 204
Peterson Amy C.0001140361-23-012614
SEC(opens sec.gov)
Jul 214
Peterson Amy C.0001567619-22-014301
SEC(opens sec.gov)
Feb 44
Peterson Amy C.0001567619-22-002525
SEC(opens sec.gov)
Oct 264
Peterson Amy C.0001567619-21-018718
SEC(opens sec.gov)
Jun 84
Peterson Amy C.0001567619-21-011806
SEC(opens sec.gov)
Mar 24
Peterson Amy C.0001567619-21-005402
SEC(opens sec.gov)
Dec 74
Peterson Amy C.0001567619-20-020709
SEC(opens sec.gov)

Companies

Address

1851 HARBOR BAY PARKWAY

ALAMEDA, CA, 94502